Interesting call. Questions lead to the following revelations.
1/ a US trip is planned in 2 weeks which may result in others warming to our technology, our candidates, and platform.
2/we could get a hint of a result within or after 6 months from the first dosing of the drug.
3/ the general market malaise in our space is making a rerate quite difficult to pick, but we should be worth more than a year ago all things being equal.
Ann: Corporate Presentation - May 2022, page-4
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
-0.015(8.11%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.0¢ | $419.2K | 2.405M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 326555 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 222720 | 4 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PYC (ASX) Chart |